JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Weber, W. A.
Right arrow Articles by Grosu, A. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Weber, W. A.
Right arrow Articles by Grosu, A. L.

Correlation Between Postoperative 3-[123I]Iodo-L-{alpha}-Methyltyrosine Uptake and Survival in Patients with Gliomas

Wolfgang A. Weber, Susanne Dick, Guenther Reidl, Brigitte Dzewas, Raymonde Busch, Horst-Jürgen Feldmann, Michael Molls, Christianto B. Lumenta, Markus Schwaiger and Anca L. Grosu

Departments of Nuclear Medicine, Radiotherapy, and Medical Statistics, Technische Universitaet Muenchen, Munich; and Department of Neurosurgery, Krankenhaus-Muenchen Bogenhausen, Munich, Germany



View larger version (126K):

[in a new window]
 
FIGURE 1. In patients with anaplastic astrocytoma, examples of IMT SPECT studies with (A) and without (B) focal IMT uptake at resection site. (A) On left, MR image (T1-weighted after administration of gadolinium-DTPA) shows resection cavity (white arrow) and rim of contrast enhancement (black arrow). Resection cavity contains blood and is, therefore, hyperintense in T1-weighted image. On right, IMT SPECT image shows intense uptake of IMT at resection margin. This patient died 6 mo after SPECT study. (B) On left, MR image shows resection cavity (white arrow) and surrounding contrast enhancement (black arrow). However, on right, IMT SPECT image shows no clear focal IMT uptake. This patient was still alive after 38 mo of follow-up.

 


View larger version (15K):

[in a new window]
 
FIGURE 2. IMT uptake and tumor grading. On left, no significant correlation (P = 0.71) is seen between IMT uptake and tumor grading in the 43 patients who were imaged after stereotactic biopsy. On right, no significant correlation (P = 0.16) is seen between IMT uptake and tumor grading in the 71 patients who were imaged after tumor resection.

 


View larger version (14K):

[in a new window]
 
FIGURE 3. Kaplan–Meier estimates of overall survival among patients with low and high postoperative IMT uptake (n = 71). In patients with IMT uptake ratio > 1.7 (high IMT uptake, n = 35), survival is significantly shorter (P < 0.001 by log-rank test) than in patients with uptake ratio <= 1.7 (low IMT uptake, n = 36).

 


View larger version (14K):

[in a new window]
 
FIGURE 4. Kaplan–Meier estimates of overall survival among untreated patients with low and high IMT uptake (n = 43). There was no significant difference (P = 0.95 by log-rank test) in overall survival between patients with IMT uptake ratio > 2.2 (high IMT uptake, n = 21) and patients with uptake ratio <= 2.2 (low IMT uptake, n = 22).

 





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2001 by the Society of Nuclear Medicine.